In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

How Device Firms Can Play the Pricing Game to Improve Franchise Value

Executive Summary

Price erosion--and its significant impact on profitability--has been a way of life for most medical device companies for years. But changes in the markeplace, particularly in GPO contracting strategies, may open the door to a re-thinking of the inevitability of price discounts. For many medical device and supply companies, the potential impact from raising the game on pricing performace is significant and available now. It can add 15-30% or more in franchise value and be a source of sustained competitive advantage.
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel